US Pharma MarketingWhy AI is changing clinical development
Why AI is changing clinical development is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
PhaseV CEO Raviv Pryluk explains how AI is reshaping trial design and execution.
Source: FierceBiotech